Lakeway, NY -- (SBWIRE) -- 02/27/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Thermo Fisher Scientific Inc. (NYSE:TMO) shares climbed 2.29% and closed at $73.24. The company yesterday announced the launch of Brilliance GBS Agar for the testing of Group B streptococci (GBS) during pregnancy. The new agar is designed to reduce the number of test steps for clinical technicians, give more reliable results, and enable faster patient treatment by featuring proprietary Inhibigen technology.
Additionally, the company announced that Marc N. Casper president and chief executive officer will present at the Cowen and Company 33rd Annual Health Care Conference being held at the Boston Marriott Copley Place Boston Mass. The presentation will take place on Tuesday March 5 2013 at 11:20 a.m. (EST).
How Should Investors Trade TMO After The Recent Price movement? Find out Here
Vale SA (ADR)(NYSE:VALE) shares jumped 2.28% to $18.42.The Company, on Feb. 18, annluced that it has declared force majeure (FM) on a number of its coal sales contracts as on February 15, 2013 and is communicating with customers as required under its agreements with them. So far, the Company estimates a loss of approximately 250,000 metric tons in metallurgical coal shipments. It will disclose further information related to the evolution of these events until the situation has been normalized.
Is VALE a Strong Buying Opportunity After The Recent Slump? Find out Here
Companhia Energetica Minas Gerais (ADR) (NYSE:CIG) shares increased 2.24% and closed at $11.87 in yesterday’s session. The 52 week trading range for the company is $10.07 - $20.97. The company is a Brazil-based holding company primarily engaged in the electricity sector. The Company is mainly active in the construction and operation of systems of production, transformation, transmission, distribution and commercialization of electric power.
Is CIG a Buy After The Latest Price Action? Find Out Here
Vitamin Shoppe Inc (NYSE:VSI) stock decreased 18.63% to $51.44. The company yesterday said its fourth-quarter net income rose 3% after a hit from Superstorm Sandy. For the quarter ended Dec. 29, the company earned $9.7 million, up from $9.4 million in the same period the year before. On a per-share basis, earnings were unchanged at 32 cents. Adjusted profit came to 40 cents in the most recent quarter. Revenue rose 2 percent to $218.9 million from $214.9 million. Analysts, on average, expected a profit of 40 cents per share on $223.2 million in revenue.
Get latest News, Updates on VSI Here
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)